Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2013
11/13/2013EP2662087A1 Somatostatin vectors
11/13/2013EP2662080A1 Nano-diamond conjugate with glycine and method for producing said conjugate
11/13/2013EP2662079A1 Uses of formulations of thyroid hormone antagonists and nanoparticulate forms thereof to increase chemosensivity and radiosensitivity in tumor or cancer cells
11/13/2013EP2662075A1 Taste masking compositions of praziquantel
11/13/2013EP2662068A1 Oil-in-water emulsion composition
11/13/2013EP2661454A1 Cationic polymers formed from amino group-bearing monomers and heterocyclic linkers
11/13/2013EP2661283A2 Cross-linked polymers and implants derived from electrophilically activated polyoxazoline
11/13/2013EP2661282A1 A pharmaceutical composition of a complex of an anti-dig antibody and digoxigenin that is conjugated to a peptide
11/13/2013EP2661281A2 Hydrophobic molecule-induced branched polymer aggregates and their use
11/13/2013EP2661280A1 O/w-emulsions comprising semifluorinated alkanes
11/13/2013EP2661273A2 Pharmaceutical compositions of iron for oral administration
11/13/2013EP2661259A2 Acoustically responsive particles with decreased cavitation threshold
11/13/2013EP2661253A1 Liposome formulation suitable for treating or preventing tuberculosis
11/13/2013EP2661251A1 Method for preparing aqueous pharmaceutical suspensions including a drug that is effective in treating rhinitis
11/13/2013EP2527360A9 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
11/13/2013CN1750839B Administration of capsaicinoids
11/13/2013CN103391778A Pharmaceutical compositions
11/13/2013CN103391768A Compostions and methods for treating chronic inflammation and inflammatory diseases
11/13/2013CN103391767A Compositions and methods for treating cardiovascular diseases
11/13/2013CN103387616A Erythropoietin (EPO) variant-Fc fusion protein
11/13/2013CN103386136A Application of hydrophobic glucan in preparation of curcumin solubilizing agent and utilization method of hydrophobic glucan
11/13/2013CN103386135A Preparation method of multifunctional medicine carrier integrating magnetism, fluorescence and thermosensitivity
11/13/2013CN103386134A Preparation method for chitosan drug-carrying microspheres by ionic cross-linking method
11/13/2013CN103386133A Oral instant preparation of proton pump inhibitor and preparation method thereof
11/13/2013CN103386132A Method for preparing stabilized ordered-molecule microcapsules from unsaturated fatty acid
11/13/2013CN103386125A Development of hemorrhagic fever with renal syndrome (HFRS) nasal mucosa immunization aerosol vaccine
11/13/2013CN103386122A Lumbrokinase enteric-coated tablet and preparation method thereof
11/13/2013CN103386117A Caspofungin preparation with low impurity content and preparation method and use thereof
11/13/2013CN103386114A Application of artificial platelet PLAG-PEG-RCD to preparing systemic nanometer styptic for veins
11/13/2013CN103386064A Traditional Chinese medicine patch
11/13/2013CN103386052A Oral preparation containing smilax glabra total glycoside and use thereof
11/13/2013CN103386011A Detoxifying plaster
11/13/2013CN103385977A Immunization functional nasal ointment
11/13/2013CN103385969A Indigo naturalis-containing traditional Chinese medicine and preparation method thereof
11/13/2013CN103385924A Traditional Chinese medicine sustained-release tablet with pain relieving effect, and preparation method thereof
11/13/2013CN103385896A Preparation method of bacterial cellulose composite flavonoid compound
11/13/2013CN103385882A Sodium ibandronate injection composition
11/13/2013CN103385880A Ursodeoxycholic acid vitamin composition, preparation method and applications thereof
11/13/2013CN103385878A Repaglinide and dimethyldiguanide pharmaceutical composition and preparation method thereof
11/13/2013CN103385876A Frovatriptan medicine composition and preparation method thereof
11/13/2013CN103385875A Nanometer chitosan artemisinin compound and preparation method thereof
11/13/2013CN103385871A Compound levodopa microcapsule floating tablet
11/13/2013CN103385863A Sodium azulene sulfonate sustained-release preparation
11/13/2013CN103385862A Metoprolol tartrate sustained-release tablet and preparation method thereof
11/13/2013CN103385861A Trimetazidine hydrochloride sustained release tablet and preparation method thereof
11/13/2013CN103385857A Pharmaceutical composition of palipeddone
11/13/2013CN103385855A Simple rapid microsphere coating method
11/13/2013CN103385852A Hydroxyfasudil injection and preparation method thereof
11/13/2013CN103385850A In-situ gel for enrofloxacin injection and preparation method thereof
11/13/2013CN102871997B Controlled-release medicinal composition containing demethyl venlafaxine benzoate compounds
11/13/2013CN102871955B Ointment medicament composition containing mupirocin
11/13/2013CN102657621B Diltiazem hydrochloride freeze-dry powder injection for injection
11/13/2013CN102626402B Monolauryl phosphate-containing lithontriptic for litholysis of cholesterol gallstone
11/13/2013CN102614147B Slow release tablet containing quetiapine fumarate
11/13/2013CN102614109B Active substance-contained gel composite based on multilayer liquid crystal framework and method for producing same
11/13/2013CN102600079B Nystatin flexible liposome as well as gel and preparation method of nystatin flexible liposome
11/13/2013CN102579407B Preparation method for indapamide microsphere sustained release capsules
11/13/2013CN102560733B Preparation of double-medicine-carrying system based on PLGA (poly(lactide-co-glycolide))-LAP (Laponite) composite nano fiber
11/13/2013CN102552181B Lansoprazole lyophilized powder injection preparation and preparing method thereof
11/13/2013CN102504081B Preparation method of medicinal methacrylate resin polymer
11/13/2013CN102440975B Metformin hydrochloride sustained-release tablets and preparation method thereof
11/13/2013CN102432755B Multi-targeted photodynamic therapy polymer carrier and preparation method thereof
11/13/2013CN102415995B Oversaturated self-microemulsified progesterone composition and preparation method of same
11/13/2013CN102399378B Temperature sensitive chitosan hydrogel and preparation method thereof
11/13/2013CN102349920B Sulfanilamide medicament composition for wound surface
11/13/2013CN102321170B Liraglutide variant and conjugate thereof
11/13/2013CN102281903B Method and formulation for reducing aggregation of a macromolecule under physiological conditions
11/13/2013CN102281902B Method and formulation for reducing aggregation of a macromolecule under physiological conditions
11/13/2013CN102149408B Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
11/13/2013CN102105553B Novel lipid dipeptide and gel
11/13/2013CN102099057B A conjugate of an antibody against CD4 and antifusogenic peptides
11/13/2013CN102038640B Liposome medicament containing cholesterol PEG modifier and preparation method thereof
11/13/2013CN101981053B Pegylated Abeta FAB
11/13/2013CN101926780B Freeze-dried preparation of stabilized anthracycline compound
11/13/2013CN101772513B Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
11/13/2013CN101687929B Monoclonal antibodies against claudin-18 for treatment of cancer
11/13/2013CN101589145B Modified soluble FGF receptor Fc fusions with improved biological activity
11/13/2013CN101478976B Polymers with antimicrobial activity containing quaternary ammonium groups
11/12/2013US8580851 Ophthalmic solution
11/12/2013US8580745 Composition for therapeutic and cosmetic botulinum toxin
11/12/2013US8580557 Casein hydrolyzate, process for producing the same and use thereof
11/12/2013US8580308 Modafinil pharmaceutical compositions
11/12/2013US8580303 Gastric retained gabapentin dosage form
11/12/2013US8580302 Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
11/12/2013US8580297 Components for producing amphoteric liposomes
11/12/2013US8580296 Pharmacokinetics of S-adenosylmethionine formulations
11/12/2013US8580295 Carbohydrates mixture
11/12/2013US8580246 Surfactant-free stable pharmaceutical composition comprising granulocyte-colony stimulating factor
11/12/2013US8580244 Cyclodextrin-based polymers for therapeutics delivery
11/12/2013US8580243 Cyclodextrin-based polymers for therapeutics delivery
11/12/2013US8580242 Cyclodextrin-based polymers for therapeutics delivery
11/12/2013CA2664637C Dried reconstituted vesicle formation for pharmaceutical application
11/12/2013CA2565250C Cysteamines for treating complications of hypercholesterolemia and diabetes
11/12/2013CA2557999C Methods and compositions for treatment of ion imbalances
11/12/2013CA2547531C Buoyant polymer particles for delivery of therapeutic agents to the central nervous system
11/12/2013CA2536643C Interferon-.beta. complex
11/12/2013CA2522098C Absorption enhancers such as bht, bha or propylgallate
11/12/2013CA2515474C Antibody molecules having specificity for human il-1.beta.
11/12/2013CA2514325C A composition material for transmucosal delivery
11/12/2013CA2490516C Honey-based skin care preparation
1 ... 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 ... 1712